gastric%20cancer
GASTRIC CANCER
Gastric cancer is the cancer originating in the esophagus, esophagogastric junction and stomach.
Most of gastric cancers are adenocarcinomas, subdivided according to histological appearances into diffuse (undifferentiated) and intestinal (well differentiated) types.
It is the 4th most common cancer and the 2nd most common cause of cancer-related deaths worldwide.
Most common sites of gastric cancer are the proximal lesser curvature, cardia and esophagogastric junction.

Follow Up

  • A regular follow-up may allow investigation & treatment of symptoms, psychological support & early detection of recurrence, though there is no evidence that it improves survival outcomes
  • Response to systemic treatments should normally be assessed with interval computed tomography (CT) imaging of chest, abdomen & pelvis
  • In the advanced disease setting, identification of patients for second-line chemotherapy & clinical trials requires regular follow-up to detect symptoms of disease progression before significant clinical deterioration
  • The type of pathological response & histologic tumor regression after neoadjuvant therapy has been shown to be a predictor of survival
  • Follow-up should include a complete history & physical examination every 3-6 months for 1-2 years, every 6-12 months for 3-5 years & annually thereafter
  • Patients who have undergone surgical resection should be monitored & treated as indicated for vitamin B12 & iron deficiency
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
DOWNLOAD
Editor's Recommendations
Most Read Articles
01 May 2014

New drug applications approved by US FDA as of 15-30 May which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

12 Apr 2017
Patients with fibromyalgia syndrome (FMS) are at an increased risk of peptic ulcer disease (PUD), a new study shows.
08 May 2017
Transabdominal bowel wall ultrasonography shows utility in monitoring disease activity in patients with active Crohn’s disease (CD), according to a study. The imaging technique is ideal for evaluating early transmural changes in disease activity, in response to medical treatment.
01 Jun 2015
A mixture of the flavonoids diosmin, troxerutin, and hesperidin is safe and effective for the symptomatic management of patients with acute haemorrhoidal disease, a prospective, randomised, triple-blind, controlled trial revealed.